Cover Image
市場調查報告書

全球週邊動脈疾病市場報告

Global Peripheral Artery Disease Market Report: 2016 Edition

出版商 Koncept Analytics 商品編碼 356937
出版日期 內容資訊 英文 52 Pages
訂單完成後即時交付
價格
Back to Top
全球週邊動脈疾病市場報告 Global Peripheral Artery Disease Market Report: 2016 Edition
出版日期: 2016年04月26日 內容資訊: 英文 52 Pages
簡介

本報告提供全球週邊動脈疾病市場相關調查,市場現狀與未來的趨勢,各分類市場趨勢,競爭環境,及參與企業簡介等彙整資料。

第1章 市場概要

  • 簡介
  • 週邊動脈疾病的原因
  • 預防
  • 診斷
    • 症狀
    • 醫療診斷
  • 治療方法
    • 經皮經管的血管成形術 (PTA)
    • 藥物塗層球囊 (DCB)
    • 支架
    • 藥劑溶出性血管支架 (DES)
    • 動脈側道
    • 動脈粥狀硬化斑塊切除術

第2章 全球週邊動脈疾病市場

  • 各銷售額
  • 罹患率
  • 設備市場

第3章 各地區市場

  • 美國
    • PAD診斷數量
    • PAD介入與普及
    • 治療與普及
    • 各銷售額市場
    • 支架/PTA治療與普及
  • EU
    • PAD診斷數量
    • PAD介入與普及

第4章 末梢動脈動脈粥狀硬化斑塊切除術市場

第5章 市場趨勢

  • 促進成長要素
  • 趨勢
  • 課題

第6章 競爭環境

  • 各企業全球週邊動脈疾病市場
  • 各企業全球末梢動脈動脈粥狀硬化斑塊切除術市場
  • 美國的末梢動脈動脈粥狀硬化斑塊切除術市場佔有率

第7章 企業簡介

第8章 市場預測

  • 全球週邊動脈疾病市場預測
  • 預測方法

圖表

目錄

Peripheral Artery Disease (PAD) is a medical condition in which plaque builds up on the artery walls, blocking the flow of oxygen-rich blood to the legs, stomach, and arms. Major factors causing PAD are smoking, diabetes, high blood pressure, abnormal cholesterol levels, advancing age and a personal history of vascular disease. The earliest symptom of Peripheral Artery Disease is a cramp-like muscular discomfort called intermittent claudication, while numbness, tingling, weakness or fatigue is also experienced. Patients with severe PAD often develop ulcers in their legs and feet. Its prevention involves a lifelong program involving certain lifestyle changes like healthy eating and physical exercise.

Medical Diagnosis of PAD includes methods like Ankle-Brachial Index, Ultrasound, Angiography, Catheter Angiography and Blood Tests. There are a number of treatment options for the disease that can be used alone or mixed with other devices. They are Percutaneous Trans Luminal Angioplasty (PTA), Drug-Coated Balloons, Stents, Drug-Eluting Stents, Arterial Bypass and Atherectomy.

The global peripheral artery disease market, bolstered by rising healthcare expenditures has seen a persistent growth in the last few years. The report provides an overview of the entire global peripheral artery disease market including the devices market and the atherectomy market. Certain key trends like increased used of DCBs and favorable reimbursements have also been discussed. Growth drivers including rising ageing population, obesity and healthcare expenditures find mention in the report along with the challenges and limitations including underpenetrated treatment market for PAD.

Competition in the global peripheral artery disease market is rather fragmented with big companies recording excellent profits while smaller companies continue to gain prevalence through research and innovation.

The report has forecasted future trend in the global Peripheral Artery Disease market by combining SPSS Inc.'s data integration and analysis capabilities. Regression models have been created by employing various significant variables that have an impact on the market. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables, and tests.

Table of Contents

1. Market Overview

  • 1.1. Introduction
  • 1.2. Causes of Peripheral Artery Disease
  • 1.3. Prevention
  • 1.4. Diagnosis
    • 1.4.1. Symptoms
    • 1.4.2. Medical Diagnosis
  • 1.5. Treatment Options for Peripheral Artery Disease
    • 1.5.1. Percutaneous Trans Luminal Angioplasty (PTA)
    • 1.5.2. Drug-Coated Balloons (DCBs)
    • 1.5.3. Stents
    • 1.5.4. Drug-Eluting Stents (DES)
    • 1.5.5. Arterial Bypass
    • 1.5.6. Atherectomy

2. Global Peripheral Artery Disease Market

  • 2.1. Global Peripheral Artery Disease Market by Value
  • 2.2. Global Peripheral Artery Disease Prevalence
  • 2.3. Global Peripheral Artery Devices Market
    • 2.3.1. Peripheral Artery Devices Market by Treatment
    • 2.3.2. Drug Eluting Stents Market by Volume
    • 2.3.3. Drug Eluting Stents Market by Geography

3. Regional Peripheral Artery Disease Market

  • 3.1. The U.S.
    • 3.1.1. The U.S. PAD Diagnosed Cases
    • 3.1.2. The U.S. PAD Interventions and Penetration
    • 3.1.3. The U.S. DCB Procedures and Penetration
    • 3.1.4. The U.S. DCB Market by Value
    • 3.1.5. The U.S. Stents/PTA Procedures and Penetration
  • 3.2. The European Union
    • 3.2.1. The EU PAD Diagnosed cases
    • 3.2.2. The EU PAD Intervention and Penetration

4. Peripheral Atherectomy Market

  • 4.1. Global Peripheral Atherectomy Market
  • 4.2. Regional Peripheral Atherectomy Market
    • 4.2.1. The U.S. Peripheral Atherectomy Market by Value
    • 4.2.2. The European Union Peripheral Atherectomy Market by Value

5. Market Dynamics

  • 5.1. Growth Drivers
    • 5.1.1. Rising Ageing Population
    • 5.1.2. Rising Proportion of Health Expenditure in Emerging Economies
    • 5.1.3. Increasing Obese Population
    • 5.1.4. Rise of Drug-Coated Balloons in the US
    • 5.1.5. Escalating Healthcare Spending
  • 5.2. Trends
    • 5.2.1. DCBs Spur Growth of Atherectomy Market
    • 5.2.2. DCB the Preferred Treatment for ISR
    • 5.2.3. Favorable Atherectomy Reimbursements
  • 5.3. Challenges
    • 5.3.1. PAD market is underpenetrated
    • 5.3.2. PAD Devices to be Hurt by DCBs
    • 5.3.3. Limitation of Peripheral Interventions

6. Competitive Landscape

  • 6.1. Global Peripheral Artery Disease Market by Company
  • 6.2. Global Peripheral Atherectomy Market by Company
  • 6.3. The US Peripheral Atherectomy Market Share

7. Company Profiles

  • 7.1. Cardiovascular Systems Inc.
    • 7.1.1. Business Overview
    • 7.1.2. Financial Overview
    • 7.1.3. Business Strategies
  • 7.2. Medtronic Plc.
    • 7.2.1. Business Overview
    • 7.2.2. Financial Overview
    • 7.2.3. Business Strategies
  • 7.3. Spectranetics Corp.
    • 7.3.1. Business Overview
    • 7.3.2. Financial Overview
    • 7.3.3. Business Strategies
  • 7.4. Boston Scientific Corp.
    • 7.4.1. Business Overview
    • 7.4.2. Financial Overview
    • 7.4.3. Business Strategies

8. Market Outlook

  • 8.1. Global Peripheral Artery Disease Market Forecast
  • 8.2. Forecast Methodology
    • 8.2.1. Dependent and Independent Variables
    • 8.2.2. Correlation Analysis
    • 8.2.3. Regression Analysis

List of Charts

  • Types of Atherosclerosis Diseases
  • Global Peripheral Artery Disease Market by Value (2008-2015E)
  • Global Peripheral Artery Disease Prevalence by Region (2015)
  • Treatment Mix for Peripheral Intervention Cases (2015)
  • Global Drug-Eluting Stents Market by Volume (2008-2015E)
  • Global Drug-Eluting Stents Volume by Geography (2008-14)
  • Diagnosed PAD Cases in the U.S. (2012-2015E)
  • PAD Interventions in the U.S (2012-2015E)
  • The US Interventional Treatment Methods by Market Share (2015)
  • DCB Procedures and Penetration Rate in the U.S. (2014-2015E)
  • The U.S. DCB Market by Value (2014-2018E)
  • Stents/PTA Procedures and Penetration Rate in the U.S. (2014-2015E)
  • Diagnosed PAD Cases in the EU (2012-2015E)
  • PAD Interventions in the EU (2012-2015E)
  • Global Peripheral Atherectomy Market (2012-2015E)
  • Total Peripheral Atherectomy Market in the U.S. (2012-2015E)
  • Total EU Peripheral Atherectomy Market (2012-2015E)
  • Global Population Over 50 Years of Age (2010-2015E)
  • Health Expenditures of China and Brazil (2008-2014)
  • Global Obese Population (2009-2014)
  • Global Healthcare Spending (2007-2014)
  • DCB use by Application Method (2015)
  • Treatment Mix for ISR Lesions (2014/2015)
  • Percentage of PAD device Usage hurt by DCBs (2015)
  • Global PAD Top Companies Revenue Comparison (2015)
  • Global PAD Top Companies CAGR Comparison (2011-2015)
  • Global Peripheral Atherectomy Market by Company (2015E)
  • The US Peripheral Atherectomy Market (2015)
  • CSII Revenue and Net Income (2011-2015*)
  • Medtronic's Market Share by Business Unit (2015*)
  • MDT Revenue and Net Income (2011-2015*)
  • SPNC's Revenue Share by Segment (2015)
  • SPNC Revenue and Net Income (2011-2015)
  • BSX Sales by Product Category (2014)
  • BSX Revenue and Net Income (2011-2015)
  • Global Peripheral Artery Disease Market Forecast (2014-2018F)

List of Tables

  • Factors Causing Peripheral Artery Disease
  • CSII's FDA Approved Peripheral Artery Disease Systems
  • Spectranetics Product by Segment
  • Dependent & Independent Variables (2010 - 2014)
  • Correlation Matrix
  • Model Summary - Coefficient of Determination
  • Regression Coefficients Output
Back to Top